|
|
Profile
|
Delegates :
|
|
Incorporated :
September 1 , 2017 |
Paid in Capital :
58 Million yen |
Employees :
3 人 |
Address :
Asahi-ku, Yokohama KANAGAWA
〒2410022
|
TEL/FAX :
+81-00-000-0000 / |
URL：
https://atDose.com/en/ |
Attachment :
 英語版ポスターA4裏表-202011.pdf [ 1.4MiB ] |
Mission/Background :
Changing the treatment method from the ground up
We have newly developed a mobile-type dosing and infusion device “atDose” (patent pending)
With this device, we aim to create a medication platform that will fundamentally change the conventional treatment of serious diseases such as cancer.
Solve previous problems to overcome
There have been various problems in the treatment by medication.
By using “atDose”, we can solve this problem and realize the dawn of medical care originating in Japan. |
|
Technology & Business
|
With this device, we aim to create a medication platform that will fundamentally change the conventional treatment of serious diseases such as cancer.
The components of the medicine taken are not all in the body due to the effects of gastric acid degradation, absorption efficiency from the small intestine, etc., but part of it passes through the liver and reaches the whole body. Ingredients are decomposed and metabolized to a small amount, and then some components reach the affected area while riding on the blood and going through the whole body. Therefore, the stronger the drug,
This is the root cause of the difficulty in finding new drugs.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Compact Mobile Drip Device “atDose Mobile”
|
Discovery
|
It frees the patient from conventional suspended drip device and bed restraints, thus contribute to improve QOL.
|
Launched as a device for animal experiments
|
Compact Infusion Pump “atDose Multi” (Patented)
|
Discovery
|
The pump can be remotely operated via a smartphone or tablet device in combination with IOT technology.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
Adopted by NEDO NEP 2018 and implemented POC.
|
|
Hot news
|
Received a corporate award at「TECH PLANTER 2019 DEMO DAY」（2019.9.21）
|
|
Alliance strategy
|
Hope for joint development with a pharmaceutical company.
|
|
|